Lindbrook Capital LLC Acquires Shares of 431 Revvity, Inc. (NYSE:RVTY)

Lindbrook Capital LLC bought a new stake in shares of Revvity, Inc. (NYSE:RVTY) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 431 shares of the company’s stock, valued at approximately $47,000.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Byrne Asset Management LLC bought a new position in shares of Revvity during the 4th quarter valued at $1,112,000. State of Michigan Retirement System acquired a new position in shares of Revvity during the 4th quarter valued at about $3,688,000. Gulf International Bank UK Ltd bought a new position in shares of Revvity in the 4th quarter valued at approximately $1,136,000. State of Alaska Department of Revenue acquired a new stake in Revvity in the 4th quarter worth approximately $1,456,000. Finally, International Assets Investment Management LLC bought a new stake in Revvity during the fourth quarter worth approximately $1,278,000. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, insider Prahlad R. Singh sold 21,217 shares of the company’s stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $104.28, for a total value of $2,212,508.76. Following the sale, the insider now directly owns 92,801 shares in the company, valued at approximately $9,677,288.28. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. UBS Group cut shares of Revvity from a “buy” rating to a “neutral” rating and boosted their price objective for the stock from $105.00 to $125.00 in a research note on Tuesday, January 16th. Raymond James boosted their target price on shares of Revvity from $106.00 to $127.00 and gave the stock an “outperform” rating in a research report on Friday, February 2nd. Evercore ISI raised Revvity from an “in-line” rating to an “outperform” rating and raised their price target for the company from $88.00 to $125.00 in a research report on Thursday, January 4th. KeyCorp boosted their price objective on Revvity from $110.00 to $126.00 and gave the stock an “overweight” rating in a research report on Friday, February 2nd. Finally, Stifel Nicolaus raised their target price on Revvity from $95.00 to $110.00 and gave the company a “hold” rating in a report on Friday, February 2nd. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, Revvity currently has an average rating of “Moderate Buy” and a consensus price target of $118.91.

Revvity Trading Down 0.6 %

Revvity stock opened at $102.09 on Friday. The business has a 50 day moving average price of $104.68 and a two-hundred day moving average price of $101.50. The company has a quick ratio of 1.77, a current ratio of 2.07 and a debt-to-equity ratio of 0.40. Revvity, Inc. has a 12 month low of $79.50 and a 12 month high of $132.54. The stock has a market cap of $12.61 billion, a price-to-earnings ratio of 18.56, a price-to-earnings-growth ratio of 2.69 and a beta of 1.09.

Revvity (NYSE:RVTY) last issued its earnings results on Thursday, February 1st. The company reported $1.25 EPS for the quarter, beating analysts’ consensus estimates of $1.15 by $0.10. The business had revenue of $695.90 million during the quarter. Revvity had a return on equity of 7.41% and a net margin of 25.20%. As a group, equities analysts forecast that Revvity, Inc. will post 4.65 EPS for the current year.

Revvity Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 9th. Investors of record on Friday, July 19th will be paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.27%. Revvity’s payout ratio is currently 5.09%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.